2018 Programme

The 2018 NCRI Conference took place between Sunday 4 November – Tuesday 6 November 2018.

Download the PDF version of the programme

Use the filters below to browse and view the full 2018 NCRI Cancer Conference programme across multiple streams and all three days.

Filter and search

Reset filters
Choose a stream [+]
Choose a session type [+]
Choose a session date [+]

Programme Details

Sunday 4 November
Sunday, 4 Nov 2018
09:00-19:00
External
2018 BASO – ACS Annual Scientific Conference
Sunday, 4 Nov 2018
13:00-13:15
Armadillo - Clyde Auditorium
Opening speech
Speaker: The Right Honourable Nicola Sturgeon, MSP, First Minister of Scotland
Sunday, 4 Nov 2018
13:15-13:55
Armadillo - Clyde Auditorium
Chromosomal order and chaos: Cancer evolution and immune evasion
Chair: Margaret Frame, University of Edinburgh, UK
Speaker: Charles Swanton, The Francis Crick Institute, UK
Sunday, 4 Nov 2018
13:55-14:35
Armadillo - Clyde Auditorium
Applying genetic information to prevent colorectal cancer
Chair: Owen Sansom, CRUK, Beatson Institute, UK
Speaker: Malcolm Dunlop, University of Edinburgh, UK
Sunday, 4 Nov 2018
14:35-15:15
Armadillo - Clyde Auditorium
Molecular imaging of immunotherapies
Chair: Gillies McKenna, CRUK/MRC Oxford Institute for Radiation Oncology, UK
Speaker: Sam Gambhir, Stanford University School of Medicine, USA
Sunday, 4 Nov 2018
15:00-00:00
Hall 4
Exhibition opens
Sunday, 4 Nov 2018
15:15-15:45
Hall 4
Coffee break, networking, exhibition and poster viewing
Sunday, 4 Nov 2018
15:20-15:40
Silent theatre 1 - Hall 4
Silent Theatre presentations
Sunday, 4 Nov 2018
15:20-15:40
Silent theatre 2 - Hall 4
Silent Theatre presentations
Sunday, 4 Nov 2018
15:45-15:50
Armadillo - Clyde Auditorium
Welcome speech from Lord Provost office
Speaker: Bailie Siddique, Glasgow City Council
Sunday, 4 Nov 2018
15:50-16:30
Armadillo - Clyde Auditorium
Brain tumours – preclinical to clinical
Chair: Margaret Frame, University of Edinburgh, UK
Speaker: Richard Gilbertson, CRUK Cambridge Institute, UK
Sunday, 4 Nov 2018
16:35-18:35
Lomond Auditorium
Tumour immunology and metabolic immunotherapy
Chair: Susan Critchlow, Astrazeneca, UK
Presenter: Marta Canel, University of Edinburgh, UK
Speaker: Martin Miller, CRUK Cambridge Institute, UK
Speaker: Saverio Tardito, CRUK Beatson Institute, UK
Speaker: Vincenzo Bronte, Federazione Ricerca Biomedica Avanzata Onlus, Italy
Sunday, 4 Nov 2018
16:35-18:35
Dochart
Melanoma discovery and medicine
Chair: Elizabeth Patton, CRUK Edinburgh Centre
Presenter: Sathya Muralidhar, University of Leeds, UK
Speaker: David Adams, Wellcome Trust Sanger Institute, UK
Speaker: Richard Marais, CRUK Manchester Institute, UK
Speaker: Richard White, Memorial Sloan Kettering Cancer Centre, USA
Sunday, 4 Nov 2018
16:35-18:35
Carron
Data driven technologies
Chair: David Weller, University of Edinburgh, UK
Speaker: Andrew Morris, Health Data Research UK
Speaker: Eva Morris, University of Leeds, UK
Speaker: Richard Martin, University of Bristol, UK
Sunday, 4 Nov 2018
16:35-18:35
M2-4
What does multi-morbidity mean for cancer treatment and outcomes
Chair: Peter Murchie, University of Aberdeen, UK
Presenter: Abdulqadr Akinoso-Imran, Queens University Belfast, UK
Presenter: Eilidh Fletcher, Information Services Division, NHS National Services Scotland, UK
Speaker: Alison Fielding, NCRI Consumer Forum, UK
Speaker: David Blane, University of Glasgow, UK
Speaker: Katriina Whitaker, University of Surrey, UK
Sunday, 4 Nov 2018
16:35-18:35
M1
Cancer research strategy and implementation
Chair: Kenneth Calman, University of Glasgow, UK
Speaker: David Dunlop, Scottish Government Chief Scientist Office, UK
Speaker: David Fitzgerald, NHS England, UK
Speaker: Iain Frame, CEO, NCRI
Speaker: Tom Crosby, Wales Cancer Network, UK
Sunday, 4 Nov 2018
16:35-18:35
Boisdale
Modelling the biology of glioblastoma
Chair: Simona Parrinello, University College London, UK
Presenter: Antonio Garcia-Trinidad, Astrazeneca, UK
Presenter: Kathreena Kurian, University of Bristol, UK
Speaker: Anthony Chalmers, University of Glasgow, UK
Speaker: Peter Dirks, Sick Kids, Canada
Speaker: Steve Pollard, University of Edinburgh, UK
Sunday, 4 Nov 2018
18:40-19:25
M1
Why is cancer so difficult? Understanding and measuring variability
Speaker: Martin Christlieb, University of Oxford, UK
Sunday, 4 Nov 2018
18:40-19:25
Hall 1
Breast Cancer Now presents ‘Science Simplified’
Sunday, 4 Nov 2018
18:40-19:25
Alsh
NCRI Trainee network event
Sunday, 4 Nov 2018
19:30-21:00
Hall 4
Civic reception, networking, poster and exhibition viewing
Sunday, 4 Nov 2018
19:40-21:00
Silent theatre 1 - Hall 4
Silent Theatre presentations
Sunday, 4 Nov 2018
19:40-21:00
Silent theatre 2 - Hall 4
Silent Theatre presentations
Sunday, 4 Nov 2018
19:45-20:55
Igloo - Hall 4
Igloo presentations

Monday 5 November
Monday, 5 Nov 2018
07:00-07:30
External
Early morning jog
Monday, 5 Nov 2018
08:15-09:00
Carron
Impact on treatment decision depending on method for Liquid Biopsy testing. Comparative study – Agena Bioscience sponsored session
Speaker: Pierre-Jean Lamy, Institut Médical d’Analyse Génomique, Montpellier, France
Monday, 5 Nov 2018
08:15-09:00
Alsh
Demystifying today’s science
Speaker: Elaine Vickers, Science Communicated Ltd, UK
Monday, 5 Nov 2018
08:15-08:45
Igloo - Hall 4
Relaxation session
Monday, 5 Nov 2018
08:15-09:00
Dochart
Dissecting the tumour microenvironment – tools for cell isolation and flow analysis – Miltenyi Biotec sponsored session
Speaker: Carsten Studte, Global Product Manager, Miltenyi Biotec, UK
Monday, 5 Nov 2018
08:15-09:00
Boisdale
Proffered papers session
Chair: Matt Seymour, NCRI and NIHR, UK
Presenter: Joanne Haviland, The Institute of Cancer Research, UK
Presenter: Nalinie Joharatnam, MRC Clinical Trials Unit at UCL, UK
Presenter: Rosalind Glasspool, Beatson West of Scotland Cancer Centre, UK
Presenter: Stephan Dreyer, University of Glasgow, UK
Monday, 5 Nov 2018
09:05-09:45
Armadillo - Clyde Auditorium
Why is behaviour change so difficult?
Chair: Linda Bauld, University of Stirling, UK
Speaker: Theresa Marteau, University of Cambridge, UK
Monday, 5 Nov 2018
09:45-10:25
Armadillo - Clyde Auditorium
Alcohol, endogenous aldehydes and DNA damage in stem cells
Chair: Owen Sansom, CRUK, Beatson Institute, UK
Speaker: KJ Patel, MRC Laboratory of Molecular Biology, UK
Monday, 5 Nov 2018
10:25-11:00
Hall 4
Coffee break, networking, exhibition and poster viewing
Monday, 5 Nov 2018
10:30-10:55
Igloo - Hall 4
Igloo presentations
Monday, 5 Nov 2018
10:30-10:55
Silent theatre 1 - Hall 4
Silent Theatre presentations
Monday, 5 Nov 2018
10:30-10:55
Silent theatre 2 - Hall 4
Silent Theatre presentations
Monday, 5 Nov 2018
11:00-12:30
Hall 1
Recent advances in cancer immunology and immunotherapy
Chair: Sergio Quezada, University College London, UK
Speaker: Burkhard Becher, University of Zurich, Switzerland
Speaker: Nicholas McGranahan, Francis Crick Institute, UK
Speaker: Sine Reker Hadrup, Technical University of Denmark, Denmark
Monday, 5 Nov 2018
11:00-12:30
Alsh
A personalised approach to treating patients with haematological malignancies
Chair: Mhairi Copland, University of Glasgow, UK
Speaker: Anna Schuh, University of Oxford, UK
Speaker: Paresh Vyas, University of Oxford, UK
Speaker: Susanne Saussele, University of Mannheim, Germany
Monday, 5 Nov 2018
11:00-12:30
Boisdale
Liquid biopsies in monitoring treatment
Chair: Nicholas Turner, The Institute of Cancer Research, UK
Speaker: Johann de Bono, The Institute of Cancer Research, UK
Speaker: Nitzan Rosenfeld, CRUK Cambridge Institute, UK
Speaker: Thomas Wurdinger, Neurosurgical Center Amsterdam, The Netherlands
Monday, 5 Nov 2018
11:00-12:30
M2-4
Environmental exposure and cancer prevention
Chair: Linda Bauld, University of Stirling, UK
Speaker: John Cherrie, Heriot Watt University, Edinburgh, UK
Speaker: Lion Shahab, University College London, UK
Speaker: Marion MacFarlane, MRC Toxicology Unit, UK
Monday, 5 Nov 2018
11:00-12:30
Carron
Proffered papers session (Prize winners)
Chair: Michelle Garrett, University of Kent, UK
Presenter: Amani Mahbub, Umm Al Qura University
Presenter: Costanza Lo Cascio, Barrow Neurological Institute, US
Presenter: Matthew Fittal, The Francis Crick Institute, UK
Presenter: Rebecca Lee, CRUK Manchester Institute, UK
Presenter: Sean Lim, University of Southampton, UK
Presenter: Seth Coffelt, Beatson Institute for Cancer Research, UK
Monday, 5 Nov 2018
11:00-12:30
Dochart
Genomics in the clinic: Context, care and communication
Chair: Sarah Cunningham-Burley, University of Edinburgh, UK
Speaker: Anne Kerr, University of Leeds, UK
Speaker: Rikke Sand Anderson, Aarhus University, Denmark
Speaker: Sophie Day, Goldsmiths, University of London, UK
Monday, 5 Nov 2018
12:30-14:00
Hall 4
Lunch, networking, exhibition and poster viewing
Monday, 5 Nov 2018
12:40-13:55
Silent theatre 1 - Hall 4
Silent Theatre presentations
Monday, 5 Nov 2018
12:40-13:55
Silent theatre 2 - Hall 4
Silent Theatre presentations
Monday, 5 Nov 2018
12:45-14:00
Carron
BASO~ACS Session: Surgical Trials Showcase and CREST Award
Chair: Richard Shaw, National Clinical Research Network
Chair: Shamaila Anwar, National Clinical Research Network
Speaker: John Edwards, Northern General Hospital
Speaker: Jonathan Gower, NIHR (CRN)
Speaker: Michael Shackcloth, Liverpool Heart and Chest Hospital
Speaker: Rakesh Heer, Newcastle University
Monday, 5 Nov 2018
13:00-14:00
Alsh
From research to reality: molecular biomarkers in immuno-oncology – Bristol-Myers Squibb sponsored session
Chair: Gary Middleton, University of Birmingham, UK
Speaker: John Gosney, Royal Liverpool University Hospital, UK
Speaker: Mike Hubank, The Royal Marsden, UK
Monday, 5 Nov 2018
13:00-14:00
M1
Dragons’ den
Monday, 5 Nov 2018
14:00-16:00
Dochart
Myeloid innate immunity
Chair: Jeffrey Pollard, University of Edinburgh, UK
Speaker: Fran Balkwill, Barts Cancer Institute, UK
Speaker: Michael Schmid, University of Liverpool, UK
Speaker: Miki De Palma, Swiss Institute for Experimental Cancer Research, Switzerland
Monday, 5 Nov 2018
14:00-16:00
Boisdale
Cancer vulnerabilities
Chair: Chris Lord, The Institute of Cancer Research, UK
Speaker: Colm Ryan, University College Dublin, Ireland
Speaker: Jason Moffatt, University of Toronto, Canada
Speaker: Rachael Natrajan, The Institute of Cancer Research, UK
Monday, 5 Nov 2018
14:00-16:00
Alsh
New approaches to cancer diagnostics, from bench to primary care
Chair: Fiona Walter, University of Cambridge, UK
Speaker: Jon Emery, University of Melbourne, Australia
Speaker: Richard Neal, University of Leeds, UK
Speaker: Steve Pereira, University College London, UK
Monday, 5 Nov 2018
14:00-16:00
M2-4
The role of the surgeon in contemporary cancer research
Chair: Terry Jones, University of Liverpool, UK
Speaker: Alex Mirnezami, University of Southampton, UK
Speaker: Christobel Saunders, University of Western Australia, Australia
Speaker: Richard Shaw, University of Liverpool, UK
Monday, 5 Nov 2018
14:00-16:00
Hall 1
Clinical impact of immunotherapy
Chair: Poulam Patel, University of Nottingham, UK
Speaker: James Larkin, Royal Marsden NHS Foundation Trust, UK
Speaker: Mary O'Brien, Royal Marsden Hospital, UK
Speaker: Paul Nathan, Mount Vernon Hospital, UK
Monday, 5 Nov 2018
14:00-16:00
Lomond Auditorium
The reality of cancer treatment consequences
Chair: Diana Greenfield, Sheffield Teaching Hospitals NHS Foundation Trust, UK
Chair: Elspeth Banks, NCRI Consumer Forum, UK
Presenter: Eila Watson, Oxford Brookes University, UK
Presenter: Hashim Ahmed, Imperial College London, UK
Speaker: Adrian Edwards, University of Cardiff, UK
Speaker: Navneet Majhail, Cleveland Clinic, USA
Speaker: Nick Robinson, BBC, Patient representative
Monday, 5 Nov 2018
14:00-16:00
Carron
Triple negative breast cancer
Chair: Adrian Harris, University of Oxford, UK
Presenter: Helena Earl, Cambridge University Hospitals, UK
Speaker: Jean Abraham, University of Cambridge, UK
Speaker: Peter Schmid, Barts Cancer Institute, UK
Speaker: Roger Daly, Monash University, Australia
Monday, 5 Nov 2018
16:00-16:30
Hall 4
Coffee break, networking, exhibition and poster viewing
Monday, 5 Nov 2018
16:05-16:30
Igloo - Hall 4
Igloo presentations
Monday, 5 Nov 2018
16:05-16:30
Silent theatre 1 - Hall 4
Silent Theatre presentations
Monday, 5 Nov 2018
16:05-16:30
Silent theatre 2 - Hall 4
Silent Theatre presentations
Monday, 5 Nov 2018
16:30-17:45
Lomond Auditorium
Best of translational science: Pancreatic cancer research
Chair: David Chang, University of Glasgow, UK
Speaker: Claus Jorgensen, CRUK, Manchester Institute, UK
Speaker: George Miller, New York Langone Medical Center, USA
Speaker: Jen Morton, CRUK, Beatson Institute, UK
Monday, 5 Nov 2018
16:30-17:45
M1
Clinical Trials Showcase
Chair: Matt Seymour, NCRI and NIHR, UK
Presenter: Alison Birtle, Lancashire Teaching Hospitals NHS Foundation Trust, UK
Presenter: Annie Young, Warwick Clinical Trials Unit, UK
Presenter: Christopher Parker, Institute of Cancer Research, Sutton; Royal Marsden Hospital, Sutton, UK
Presenter: Janet Dunn, University of Warwick, UK
Presenter: Janusz Jankowski, Royal College of Surgeons Ireland National; Institute for Health and Care Excellence; University Hospitals of Morecambe Bay NHS Trust
Presenter: Jon Wadsley, Weston Park Hospital, UK
Monday, 5 Nov 2018
17:50-18:30
Armadillo - Clyde Auditorium
CRUK Prizes session and Lifetime Achievement
Monday, 5 Nov 2018
19:30-23:59
Crowne Plaza Hotel
Conference social event

Tuesday 6 November
Tuesday, 6 Nov 2018
08:15-09:00
Boisdale
Demystifying today’s science
Speaker: Elaine Vickers, Science Communicated Ltd, UK
Tuesday, 6 Nov 2018
08:15-09:00
Alsh
A career in cancer research: What industry has to offer
Chair: Sue Bailey, Bristol-Myers Squibb, UK
Tuesday, 6 Nov 2018
08:15-08:45
Igloo - Hall 4
Relaxation session
Tuesday, 6 Nov 2018
08:15-09:00
Carron
Why 3D imaging in preclinical trials is a step forward for cancer research – Fuel3D Sponsored session
Tuesday, 6 Nov 2018
08:15-09:00
Dochart
Proffered papers session
Chair: Fiona Walter, University of Cambridge, UK
Presenter: Chit Fang Cheok, Institute of Molecular and Cell Biology (IMCB), Singapore
Presenter: Jo Brett, Oxford Brookes University, UK
Presenter: Richard Shaw, University of Liverpool, UK
Presenter: Samantha Quaife, University College London, UK
Tuesday, 6 Nov 2018
09:00-15:30
Forth
Schools event
Tuesday, 6 Nov 2018
09:05-09:45
Armadillo - Clyde Auditorium
Cell function and tumour formation
Chair: Eric O'Neill, University of Oxford, UK
Speaker: Stefano Piccolo, University of Padua, Italy
Tuesday, 6 Nov 2018
09:45-10:25
Armadillo - Clyde Auditorium
Microbiome and mucosal immunology
Chair: Pippa Corrie, Cambridge University Hospitals, UK
Speaker: Fiona Powrie, Kennedy Institute of Rheumatology, UK
Tuesday, 6 Nov 2018
10:25-11:00
Hall 4
Coffee break, networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
10:30-10:55
Silent theatre 1 - Hall 4
Silent Theatre presentations
Tuesday, 6 Nov 2018
10:30-10:55
Igloo - Hall 4
Igloo presentations
Tuesday, 6 Nov 2018
10:30-10:55
Silent theatre 2 - Hall 4
Silent Theatre presentations
Tuesday, 6 Nov 2018
11:00-12:30
Hall 1
Cancer heterogeneity
Chair: Mariam Jamal-Hanjani, University College London Cancer Institute, UK
Speaker: Kevin Litchfield, The Francis Crick Institute, UK
Speaker: Peter Van Loo, The Francis Crick Institute, UK
Speaker: Trevor Graham, Barts Cancer Institute, UK
Tuesday, 6 Nov 2018
11:00-12:30
M1
New cancer therapies
Chair: Caroline Springer, CRUK Manchester Institute, UK
Speaker: Allan Jordan, CRUK Manchester Institute, UK
Speaker: Ian Collins, The Institute of Cancer Research, UK
Speaker: John Bell, University of Ottawa, Canada
Tuesday, 6 Nov 2018
11:00-12:30
Carron
Population cancer screening: are we getting it right?
Chair: Ian Tomlinson, University of Birmingham, UK
Speaker: Linda Sharp, Newcastle University, UK
Speaker: Mette Kalager, University of Oslo, Norway
Speaker: Richard Martin, University of Bristol, UK
Tuesday, 6 Nov 2018
11:00-12:30
Boisdale
The promise of precision
Chair: Tim Maughan, University of Oxford, UK
Speaker: Cindy Billingham, University of Birmingham, UK
Speaker: Peter O'Dwyer, University of Pennsylvania, USA
Speaker: Richard Wilson, Queen's University Belfast, UK
Tuesday, 6 Nov 2018
11:00-12:30
Lomond Auditorium
Spotlight on NCRI activities: Living with and beyond cancer initiative
Chair: Richard Stephens, NCRI Consumer Forum, UK
Speaker: Andrew Bottomley, European Organisation for Research and Treatment of Cancer (EORTC), Belgium
Speaker: Ceinwen Giles, Shine Cancer Support, UK
Speaker: Galina Velikova, University of Leeds, UK
Speaker: Sam Ahmedzai, University of Sheffield, UK
Tuesday, 6 Nov 2018
11:00-12:30
Dochart
Digital pathology
Chair: Karin Oien, University of Glasgow, UK
Speaker: Manuel Salto-Tellez, Queen's University Belfast, UK
Speaker: Nasir Rajpoot, University of Warwick, UK
Speaker: Yinyin Yuan, The Institute of Cancer Research, UK
Tuesday, 6 Nov 2018
12:30-14:00
Hall 4
Lunch, networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
12:40-13:55
Silent theatre 1 - Hall 4
Silent Theatre presentations
Tuesday, 6 Nov 2018
12:40-13:55
Silent theatre 2 - Hall 4
Silent Theatre presentations
Tuesday, 6 Nov 2018
13:00-14:00
Carron
Proffered papers session
Chair: Nitzan Rosenfeld, Cancer Research UK Cambridge Institute, UK
Presenter: Adam Hall, Institute of Genetics and Molecular Medicine, The University of Edinburgh, UK
Presenter: Amy Downing, University of Leeds, UK
Presenter: Arafath Najumudeen, Beatson Institute for Cancer Research, UK
Presenter: Ben O'Leary, The Institute of Cancer Research, UK
Presenter: Meda Sandu, University of Bristol, UK
Presenter: Michael Hodder, CRUK Beatson Institute, UK
Tuesday, 6 Nov 2018
13:00-14:00
Alsh
Meet the expert
Chair: Owen Sansom, CRUK, Beatson Institute, UK
Speaker: Chris Lord, The Insitute of Cancer Research, UK
Speaker: Elizabeth Patton, CRUK Edinburgh Centre, UK
Speaker: Gemma Pearce, Coventry University, UK
Speaker: Maria Hawkins, CRUK MRC Oxford Institute for Radiation Oncology, UK
Speaker: Pippa Corrie, Cambridge University Hospitals, UK
Speaker: Terry Jones, University of Liverpool, UK
Tuesday, 6 Nov 2018
13:00-14:00
Boisdale
Advances in pancreatic and biliary tract cancers: investigators’ perspectives – NuCana sponsored workshop
Speaker: Dan Palmer, University of Liverpool & Clatterbridge Cancer Centre
Speaker: Juan W. Valle, Christie Hospital Manchester, UK
Speaker: Mairéad McNamara, Christie Hospital, Manchester, UK
Tuesday, 6 Nov 2018
14:00-16:00
Boisdale
Understanding the role of TGFbeta signalling in cancer
Chair: Gareth Inman, University of Dundee, UK
Presenter: Madelon Paauwe, Beatson Institute for Cancer Research, UK
Speaker: Carl-Henrik Heldin, The Ludwig Institute for Cancer Research, UK
Speaker: Caroline Hill, The Francis Crick Institute, UK
Speaker: Joan Seoane, Val D’Hebron Institute of Oncology, Spain
Tuesday, 6 Nov 2018
14:00-16:00
Lomond Auditorium
Impact of a patient’s gut microbiome on clinical response to cancer immunotherapy
Chair: Trevor Lawley, Wellcome Trust Sanger Institute
Speaker: Paul O'Toole, University College Cork, Ireland
Speaker: Robert Jenq, MD Anderson Cancer Center, USA
Speaker: Trevor Lawley, Wellcome Trust Sanger Institute, UK
Tuesday, 6 Nov 2018
14:00-16:00
Hall 1
The burden of cancer due to inequalities and its likely causes
Chair: Yoryos Lyratzopoulos, University College London, UK
Speaker: Bernard Rachet, London School of Hygiene and Tropical Medicine, UK
Speaker: Jo Waller, University College London, UK
Speaker: Nancy Keating, Harvard Medical School and Dana Farber. USA
Tuesday, 6 Nov 2018
14:00-16:00
M1
Radiotherapy combinations
Chair: Maria Hawkins, CRUK MRC Oxford Institute for Radiation Oncology, UK
Speaker: Alan Melcher, The Institute of Cancer Research, UK
Speaker: Kaye Williams, The University of Manchester, UK
Speaker: Susan Short, University of Leeds, UK
Tuesday, 6 Nov 2018
14:00-16:00
Alsh
The challenge of rare cancers
Chair: Richard Adams, University of Cardiff, UK
Presenter: Charleen Chan Wah Hak, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
Speaker: Matt Sydes, University College London, UK
Speaker: Sheela Rao, Royal Marsden Hospital, UK
Speaker: Steve Nicholson, International Rare Cancers Initiative in Penile Cancer, UK
Tuesday, 6 Nov 2018
14:00-16:00
Dochart
Measuring what matters to healthcare professionals, patients and service providers
Chair: Lesley Fallowfield, University of Sussex, UK
Speaker: Angus McNair, NIHR, UK
Speaker: David Cella, CORE Core Outcomes Research Centre, Chicago, USA
Speaker: Derek Kyte, University of Birmingham, UK
Tuesday, 6 Nov 2018
14:00-16:00
Carron
Ovarian cancer – novel models and novel targets
Chair: Iain McNeish, Imperial College London, UK
Speaker: Ahmed Ahmed, University of Oxford, UK
Speaker: Charlie Gourley, University of Edinburgh, UK
Speaker: Stephen Taylor, University of Manchester, UK
Tuesday, 6 Nov 2018
16:00-16:30
Hall 4
Coffee break, networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
16:05-16:30
Igloo - Hall 4
Igloo presentations
Tuesday, 6 Nov 2018
16:05-16:30
Silent theatre 1 - Hall 4
Silent Theatre presentations
Tuesday, 6 Nov 2018
16:05-16:30
Silent theatre 2 - Hall 4
Silent Theatre presentations
Tuesday, 6 Nov 2018
16:30-17:10
Armadillo - Clyde Auditorium
Head and neck cancer treatments
Chair: Terry Jones, University of Liverpool, UK
Speaker: Quynh-Thu Le, Stanford University, USA
Tuesday, 6 Nov 2018
17:10-17:30
Armadillo - Clyde Auditorium
Closing remarks